Critical Care Nurse Student | Assistant Clinical Researcher | Chairperson National Nurses of Kenya-Siaya Branch | Mentor | SRHR & Boys Advocate.
Young and energetic healthcare professional with a strong belief in the basic tenets of human development and quality of life. My key qualities include integrity, hardworking, team player and keenness to achieve results.
Critical Care Nurse Student | Assistant Clinical Researcher | Chairperson National Nurses of Kenya-Siaya Branch | Mentor | SRHR & Boys Advocate.
Young and energetic healthcare professional with a strong belief in the basic tenets of human development and quality of life. My key qualities include integrity, hardworking, team player and keenness to achieve results.
shock is the state of insufficient blood flow to the tissues of the body .it contains introduction, definition, stages of shock, types of shock, diagnostic evaluation, prognosis ,prevention, care for each stage.
A very narrative discussion over Shock & Haemorrhage, Blood Transfusion, Blood Products which is presented in seminers. A concise guideline of a vast chapter.
Subject: Medical Surgical Nursing / Adult Health Nursing
Title: Shock
Prepared by: Misfa Khatun, Nursing tutor
Content:
- Introduction
- Definition of Shock
- Classify Shock
- Stages of Shock
- Enumerate the Causes of shock
- Pathophysiology of Shock
- Identify the Signs and symptoms of Shock
- First ais management of Shock
- Treatment of Shock
- Management of Shock
- Nursing management of Shock
shock is the state of insufficient blood flow to the tissues of the body .it contains introduction, definition, stages of shock, types of shock, diagnostic evaluation, prognosis ,prevention, care for each stage.
A very narrative discussion over Shock & Haemorrhage, Blood Transfusion, Blood Products which is presented in seminers. A concise guideline of a vast chapter.
Subject: Medical Surgical Nursing / Adult Health Nursing
Title: Shock
Prepared by: Misfa Khatun, Nursing tutor
Content:
- Introduction
- Definition of Shock
- Classify Shock
- Stages of Shock
- Enumerate the Causes of shock
- Pathophysiology of Shock
- Identify the Signs and symptoms of Shock
- First ais management of Shock
- Treatment of Shock
- Management of Shock
- Nursing management of Shock
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. Objectives:
At the end of this Lecture you would be able to :
Define and Classify Shock.
Differentiate the various Categories of Shock.
Describe Pathophysiology of Shock.
Identify Etiology and Clinical Features of Shock.
3. Definition
A condition in which the Cardiovascular System fails to perfuse
tissues adequately resulting in decreased tissue oxygen delivery.
Life-threatening medical emergency characterized by inability of the
body to adequately circulate blood to the body cells to supply
enough oxygen and nutrients to meet tissue requirements and
remove metabolic waste.
4. Definition
•It can also be defined as a life-threatening in which blood
flow to the organs is low, decreasing delivery of oxygen,
nutrients and removal of waste thus causing organ damage
and sometimes death.
5. Definition of hemodynamic terms
•Perfusion: supply of Oxygen and nutrients to and removal
of wastes from cells and tissues of body as a result of
adequate flow of blood through capillaries.
•Hypoperfusion: inability of body to adequately circulate
blood to body’s cells to supply them with oxygen, nutrients
and remove waste.
6. Definition of hemodynamic terms
• Stroke Volume (SV): amount of blood pumped into aorta by
contraction of left ventricle per heart beat.
• Cardiac Output (CO): amount of blood pumped into aorta by
contraction of left ventricle in one minute.
7. Hypotension:
•Hypotension is the medical term for low Blood Pressure-
less than 90/60.
•In Adults:
•Systolic BP 90mmHg.
•Mean Arterial Pressure 60 mmHg.
•Decreased Systolic BP > 40 mmHg(not always the
case) from the patient’s baseline pressure.
8. Note
Hypoperfusion can be present in the absence of
significant Hypotension.”
“Shock can occur with normal Blood Pressure and
Hypotension can occur without Shock”. Example, in
cardiogenic shock
9. Physiological principles
Tissue Perfusion is driven by Blood Pressure
Blood Pressure = Cardiac Output x Systemic Vascular
Resistance OR Total Peripheral Resistance (TPR)
(BP = CO X SVR)
Cardiac Output = Stroke Volume x Heart Rate
(CO = SV x HR)
10. Basic pathophysiology
• 1. Fall in Flow:
• Haemorrhage
• Diarrhoea/vomiting
• Burns
• PE
• Tension Pneumothorax
• Tamponade
• Myocardial Infarction
• Cardiac Failure
Volume Loss
(Hypovolemic
)
Fall in Flow
(Low Cardiac Output)
Fall in Filling
(Obstructive)
Fall in
Contractility
(Cardiogenic)
11. Basic Pathophysiology
• 2. Fall in Resistance:
• Sepsis
• Anaphylaxis
• Spinal Cord Injury
• Liver Failure
• Vasodilation results in a drop in Systemic or Peripheral Vascular
Resistance.
• In order to maintain Blood Pressure, Cardiac Output increases resulting in
warm peripheries with a rapid, bounding pulse (high output” shock).
Vasodilation
(Distributive)
Fall in
Resistance
12. Compensatory Mechanisms
Most immediate of compensatory mechanisms are those of
Sympathetic Nervous System and Renin Angiotensin Mechanism.
Sympathetic Nervous System:
NE, Epinephrine, and Cortisol released
Cause vasoconstriction, increase in HR, and increase of
Cardiac Contractility (Cardiac Output)
Renin-Angiotensin mechanism:
Water and Sodium Conservation and Vasoconstriction
(aldosterone)
Increase in Blood Volume and Blood Pressure
12
13. Cellular Response to Shock
Blood
Loss
Inadequate
Perfusion
Cellular
Hypoxia
Aerobic
Metabolism
Anaerobic
Metabolism
Lactic
Acid
Cellular
Edema
Acidosis
Cellular
Death
14. Classification of Shock
4 main etiologies of shock include:
Hypovolemic: Low cardiac output due to low intravascular volume.
Cardiogenic: Low cardiac output despite adequate intravascular
volume.
Distributive: Low total peripheral or systemic vascular resistance,
usually septic.
Obstructive: Low cardiac output due to outflow obstruction.
15. Hypovolemic shock
1. Hemorrhage
a. Trauma
b. Gastrointestinal hemorrhage
c. Postsurgical, post procedural bleeding
d. Intra-abdominal (e.g., abdominal aortic
aneurysm, ruptured ectopic pregnancy)
2. Volume depletion
a. Vomiting
b. Diarrhea
c. Excessive diuresis (from diuretics or
uncontrolled diabetes). D: Burns
17. Obstructive shock
Outflow Obstruction:
a. Aortic stenosis
b. Hypertrophic cardiomyopathy
c. Pulmonary embolism (PE)
Reduced filling
a. Constrictive pericarditis
b. Tension pneumothorax
c. Mitral stenosis
18. Distributive shock
1. Septic shock; as a result of severe infection in the blood.
2. Anaphylactic shock; as a result of severe allergic reaction.
3. Neurogenic shock; as a result of injury to the spinal cord.
19. Stages of shock
•Initial stage- tissues are under perfused, decreased cardiac
output without signs and symptoms.
•Compensatory/reversible stage- activation of sympathetic
nervous system and renin-angiotensin system.
20. Stages of shock
Progressive stage- if there is no interventions or if
interventions fails, compensatory mechanisms worsen cardiac
state leading to anerobic metabolic metabolism and acidosis.
Cardiologist care required for cardiogenic shock.
Refractory/irreversible stage- survival is extremely limited,
complications such as cardiopulmonary arrest, dysrhythmias,
multiple organ failure, stroke and death.
21. Classification of hypovolemic shock
Class I Class II Class III Class IV
Blood Loss- ml < 750ml 750-1500ml 1500-2000ml >2000ml
Blood Loss-%
Volume
<15% 15-30% 30-40% >40%
Pulse rate <100/min >100/min 120-140/min >140/min
Blood Pressure Normal Normal
Pulse Pressure Normal
Capillary refill Normal + + +
Respiratory rate 14-20/min 20-30/min 30-40/min >40/min
Urinary output >30ml/Hour 20-30 ml/Hour 5-15ml/Hour Anuria
Mental status Mild anxiety Anxiety Confused Lethargic
Fluid Crystalloid Crystalloid Blood Blood
23. Clinical Presentation of Hypovolemic Shock
Tachycardia and tachypnea
Weak, thread, fast pulses
Hypotension
Skin cool & clammy
Mental status changes
Decreased urine output: dark & concentrated
Signs
• cardiac output
• SVR
24. Shock Index (SI)
Heart Rate divided by Systolic Blood Pressure. (Normal range- 0.5 to 0.7
in healthy adults).
Suggested as marker used to predict severity of Hypovolemic Shock.
Classification of Hypovolemic Shock based on SI enables fast and reliable
assessment of Hypovolemic Shock in emergency department.
SI <0.6 (No Shock), SI ≥0.6 to <1.0 (Mild Shock), SI ≥1.0 to <1.4
(Moderate Shock) and SI ≥1.4 (Severe Shock).
25. Classification of Hypovolemic Shock based on the Shock Index (SI)
Class I Class II Class III Class IV
Shock No Shock Mild Shock Moderate Shock Severe Shock
SI at admission <0.6 ≥0.6 to <1 ≥1 to <1.4 ≥1.4
Need of Blood
products
Observe Consider use of
Blood products
Prepare Transfusion Prepare massive
Transfusion
SI based classification is an easy and reliable tool to identify trauma
patients at risk for the need of blood products.
26. Mgt of shock
• Assessment- ABCDE approach
• High concentration of oxygen
• Keep patient warm
• Specific treatment dependind on cause of shock.
• Transport
27. Initial management of hypovolemic shock
Management Goal: Restore Circulating Volume, Tissue
Perfusion, & Correct Cause:
Early Recognition- Do not rely on BP! (30% fluid loss).
Control Hemorrhage.
Restore Circulating Volume.
Optimize Oxygen Delivery.
Vasoconstrictor if BP still low after Volume Loading.
28. Management of hypovolemic shock cont.
ABCs.
Establish 2 large bore IVs or a Central Line.
Crystalloids
Normal Saline or Lactate Ringers
Up to 3 liters using fluid challenge.
Packed Red Blood Cells
O Negative or Cross Matched.
Control any Bleeding.
Arrange Definitive Treatment.
29. Fluid Challenge
250-500ml over 5-15 min
Assess response:
No response
Transient response
Sustained response
If no/transient response- REPEAT
If you suspect Cardiac cause, or patient known to have Heart Failure- use
100-200ml instead
30. Clinical presentation of cardiogenic shock
Signs:
Cool, mottled skin
Tachypnea
Hypotension
Altered Mental Status
Narrowed Pulse Pressure
Rales, Murmur
Defined as:
SBP < 90 mmHg
CI: <1.8 L/min per m2
without support)
31. Management of cardiogenic shock:
Goals- Airway stability and improving Myocardial Pump
Function.
Cardiac Monitor, Pulse Oximetry.
Supplemental Oxygen, IV access.
Be prepared to give Fluid Bolus